Jefferies Initiates Coverage On Pardes Biosciences with Buy Rating, Announces Price Target of $25
Jefferies analyst Dennis Ding initiates coverage on Pardes Biosciences (NASDAQ:PRDS) with a Buy rating and announces Price Target of $25.
63 Biggest Movers From Yesterday
Gainers
Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) shares surged 93.2% to close at $1.70 on Thursday. Kiora Pharmaceuticals recently appointed David Hollander, MD, MBA, to its Board of Directors.
44 Stocks Moving In Thursday’s Mid-Day Session
Gainers
Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) jumped 52.3% to $1.3396. Kiora Pharmaceuticals recently appointed David Hollander, MD, MBA, to its Board of Directors.